Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pET-28a-hPKM2 Citations (4)

Originally described in: Pyruvate kinase M2 is a phosphotyrosine-binding protein.
Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC Nature. 2008 Mar 13;452(7184):181-6. doi: 10.1038/nature06667.
PubMed Journal

Articles Citing pET-28a-hPKM2

Articles
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. Shankar Babu M, Mahanta S, Lakhter AJ, Hato T, Paul S, Naidu SR. PLoS One. 2018 Feb 2;13(2):e0191419. doi: 10.1371/journal.pone.0191419. eCollection 2018. PubMed
CARM1 suppresses de novo serine synthesis by promoting PKM2 activity. Abeywardana T, Oh M, Jiang L, Yang Y, Kong M, Song J, Yang Y. J Biol Chem. 2018 Sep 28;293(39):15290-15303. doi: 10.1074/jbc.RA118.004512. Epub 2018 Aug 21. PubMed
Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity. Verma K, Patel A. PLoS One. 2019 Feb 8;14(2):e0211515. doi: 10.1371/journal.pone.0211515. eCollection 2019. PubMed
Purification and Characterization of Prolyl Hydroxylase 3/Pyruvate Kinase Isoform 2 Protein Complex. Kumar S, Patel AK. Mol Biotechnol. 2020 Feb;62(2):111-118. doi: 10.1007/s12033-019-00228-9. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.